F. Bosch and N. Munoz, “Hepatocellular Carcinoma in the World: Epidemiologic Questions,” In: E. Tabor, A. DiBisceglie and R. Purcell, Eds., Etiology, Pathology and Treatment of Hepatocellular Carcinoma in America. Advances in Applied Technology Series, Gulf, Houston, 1991, p. 35.

has been cited by the following article:

• TITLE: Multi-Detector-Row CT Diagnosis of Adrenal Incidentaloma in Patients with Hepatocellular Carcinoma

  AUTHORS: Taisuke Harada, Tamotsu Kamishima, Satoshi Terae, Yuya Onodera, Hiroki Shirato

  KEYWORDS: CT; Adrenal Incidentaloma; Hepatocellular Carcinoma; Lipid-Poor Adrenal Adenomas; Metastatic Adrenal Tumors

  JOURNAL NAME: Advances in Computed Tomography, Vol.2 No.1, March 28, 2013

  ABSTRACT: We investigate the diagnostic reliability of differentiating between lipid-poor adrenal adenomas and metastatic adrenal tumors originating from hepatocellular carcinoma (HCC) using a routine dynamic CT protocol for liver imaging. Eighteen metastatic adrenal tumors originating from HCC and 13 lipid-poor adrenal adenomas were identified. Dynamic CT data were analyzed for CT attenuation of adrenal lesions before and after contrast administration. When a cutoff of 36 HU was set for adrenal lesions at pre-contrast attenuation, the sensitivity and specificity for the diagnosis of metastatic lesions were 94.4%and 92.3%, respectively. Attenuation criteria on pre-contrast CT may help optimize the differentiation between these lesions.